𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of the Veterinary Pharmaceutical Ivermectin in Indoor Aquatic Microcosms

✍ Scribed by Harry Boonstra; Erik P. Reichman; Paul J. van den Brink


Publisher
Springer
Year
2010
Tongue
English
Weight
496 KB
Volume
60
Category
Article
ISSN
0090-4341

No coin nor oath required. For personal study only.

✦ Synopsis


The effects of the parasiticide ivermectin were assessed in plankton-dominated indoor microcosms. Ivermectin was applied once at concentrations of 30, 100, 300, 1000, 3000, and 10,000 ng/l. The half-life (dissipation time 50%; DT~50~) of ivermectin in the water phase ranged from 1.1 to 8.3 days. The lowest NOEC~community~ that could be derived on an isolated sampling from the microcosm study by means of multivariate techniques was 100 ng/l. The most sensitive species in the microcosm study were the cladocerans Ceriodaphnia sp. (no observed effect concentration, NOEC = 30 ng/l) and Chydorus sphaericus (NOEC = 100 ng/l). The amphipod Gammarus pulex was less sensitive to ivermectin, showing consistent statistically significant reductions at the 1000-ng/l treatment level. Copepoda taxa decreased directly after application of ivermectin in the highest treatment but had already recovered at day 20 posttreatment. Indirect effects (e.g., increase of rotifers, increased primary production) were observed at the highest treatment level starting only on day 13 of the exposure phase. Cladocera showed the highest sensitivity to ivermectin in both standard laboratory toxicity tests as well as in the microcosm study. This study demonstrates that simple plankton-dominated test systems for assessing the effects of ivermectin can produce results similar to those obtained with large complex outdoor systems.


📜 SIMILAR VOLUMES


How to test nontarget effects of veterin
✍ Ralf Jochmann; Wolf U Blanckenhorn; Luc Bussière; Charles E Eirkson; John Jensen 📂 Article 📅 2010 🏛 Society of Environmental Toxicology and Chemistry 🌐 English ⚖ 270 KB

## Abstract To register veterinary medicinal products (VMPs) as parasiticides on pastured animals, legislation in the European Union requires an environmental risk assessment to test the potential nontarget effects of fecal residues on dung‐dwelling organisms. Products with adverse effects in singl